BrightGene Bio-Medical Technology Co., Ltd. (SHSE:688166) announces a share repurchase program. Under the program, the company will repurchase up to CNY 20 million worth of its shares. The repurchase price will not be more than CNY 43.13 per share.

The shares repurchased will be used for equity incentives or employee stock ownership plans. Repurchases will be funded using the company?s own funds. The repurchase period will not be more than 12 months.